Beneficial effect of Iloprost® on impaired colonic anastomotic healing induced by intraperitoneal 5-fluorouracil infusion

Diseases of the Colon and Rectum

Volumn 41, Issue 5, 1998, Pages 642-648

  Bostanoǧlu, Settar ^a,c   Di̊nçer, Sibel ^b   Keski̊n, Ayhan ^a   Bostanoǧlu, Akin ^a   Dursun, Ayşe ^b   Seri̊m, Çetin ^a  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

5 Fluorouracil; Healing of colon anastomoses; Iloprost

Indexed keywords

ILOPROST; PROSTACYCLIN DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CELL PROTECTION; COLON ANASTOMOSIS; COLON RESECTION; COLON SURGERY; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; WOUND HEALING;

ANASTOMOSIS, SURGICAL; ANIMALS; COLON; FLUOROURACIL; HYDROXYPROLINE; ILOPROST; MALE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; TIME FACTORS; VASODILATOR AGENTS; WOUND HEALING;

EID: 0345487547     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02235275     Document Type: Article

References (32)

1. Grem JL. Current treatment approaches in colorectal cancer. Semin Oncol 1991;18(Suppl 1):17-26.
2. Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsk I, Meyers CE. Prospective randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985;98:414-21.
3. Goldie JH, Goldman AJ. The genetic origin of drug resistance in neoplasms: implications for systematic therapy. Cancer Res 1984;44:3643-53.
4. Gündüz N, Fisher BV, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861-5.
5. Cunliffe WS, Sugarbaker PH. Gastrointestinal malignancy: rationale for adjuvant therapy using early post-operative intraperitoneal chemotherapy. Br J Surg 1989; 76:1082-90.
6. Graf W, Weiber S, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Influence of 5-fluorouracil and folinic acid on colonie healing an experimental study in the rat. Br J Surg 1992;79:825-8.
7. Weiber S, Graf W, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Experimental colonie healing in relation to timing of 5-fluorouracil therapy. Br J Surg 1994;81: 1677-80.
8. Martens MF, Hendriks T, Wobbes T, De Pont JJ. Intraperitoneal cytostatics impair early post-operative collagen synthesis in experimental intestinal anastomoses. Br J Cancer 1992;65:649-54.
9. De Roy Zuidewijn DB, Wobbes TH, Hendriks TH. The effects of antineoplastic agents on the healing of small intestinal anastomoses in the rat. Cancer 1986;58:62-6.
10. De Roy Zuidewijn DB, Hendriks TH, Wobbes TH. Intraperitoneal cytostatics impair healing of experimental intestinal anastomoses. Br J Cancer 1991;63:937-41.
11. Weiber S, Graf W, Glimelius B. The effect of 5-fluorouracil on wound healing and collagen synthesis in left colon anastomoses: an experimental study in the rat. Eur Surg Res 1994;26:173-8.
12. Gottrup F. Healing of incisional wounds in stomach and doudenum. Am J Surg 1981;141:222-7.
13. Gryglewski RJ. The impact of prostacyclin studies on the development of its stable analogues. In: Gryglewski RJ, Stock G, eds. Prostacyclin and its stable analogue iloprost. Berlin: Springer-Verlag, 1987:3-15.
14. Aksulu HE, Türker RK. Iloprost (ZK 36 374) prevents angiotensin I conversion in the isolated perfused rat lung against anoxia. Eur J Pharmacol 1986;128:67-72.
15. Hamilton J, Subbarao V, Granack K. Platelet interaction with a pancreatic ascites tumor. Am J Pathol 1986;122: 160-3.
16. Hann KV, Vicone B, Skoff A. Prostacyclin: a potent antimetastatic agent. Science 1981;212:1270-5.
17. Menter DG, Gonoda JM, Taylor JD. Effects of prostacyclin on tumor cell-induced platelet aggregation. Cancer Res 1984;44:450-2.
18. Konturek SJ, Robert A. Cytoprotection of canine gastric mucosa by prostacyclin: possible meditation by increased mucosal blood flow. Digestion 1982;25: 155-7.
19. Moncada S, Whittle BJ. Biological actions of prostacy-clin and its pharmacological use in platelet studies. Adv Exp Med Biol 1985;192:337-41.
20. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961;93: 440-7.
21. Gyves J. Pharmacology of intraperitoneal infusion 5-fluorouracil and mitomycin-C. Semin Oncol 1985;12(Suppl 4):9-32.
22. Speyer JL, Sugarbaker PH, Collins JM. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res 1981; 41:1916-22.
23. Fielding FP, Steward BS. Anastomotic integrity after operations for large bowel cancer: a multicenter study. BMJ 1980;281:911-8.
24. Morris T. Retardation of healing of large-bowel anastomoses by 5-fluorouracil. Aust N Z J Surg 1979;49:743-5.
25. Sasaki T, Holeyfield KC, Utto J. Doxorubicin induced inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures. J Clin Invest 1987;80:1735-8.
26. Ballantyne GH. The experimental basis of intestinal suturing: effect of surgical technique, inflammation, and infection on enteric wound healing. Dis Colon Rectum 1984;27:61-4.
27. Robert A. On the mechanism of cytoprotection by prostaglandins. Ann Clin Res 1984;16:335-9.
28. Whittle BJ, Kaufmann GL, Bouhton NK. Stimulation of gastric alkaline secretion by stable prostacyclin analogues in rat and dogs. Eur J Pharmacol 1984;100: 277-81.
29. 2 in the isolated various vascular smooth muscle strips of the rabbit. Pharmacology 1985; 31:61-4.
30. 1 on colonic anastomotic healing: a comparison study. Dis Colon Rectum 1990;33:44-8.
31. Diegelmann RF, Cofren IK, Kaplan AM. The role of macrophages in wound repair: a review. Plast Reconstr Surg 1981;68:107-12.
32. Leibovich SJ, Ross R. The role of the macrophage in wound repair. Am J Pathol 1975;78:71-91.